2026 Global: Animal Therapeutics And Diagnostics-Competitive Review (2032) report
Description
The 2026 Global: Animal Therapeutics And Diagnostics-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for animal therapeutics and diagnostics by geography and historical trend. The scope of the report extends to sizing of the animal therapeutics and diagnostics market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Zoetis leads the animal therapeutics and diagnostics sector with a broad portfolio spanning vaccines, pharmaceuticals, diagnostics, and digital solutions for both companion animals and livestock, supported by sizable R&D investments and global manufacturing and distribution networks. Merck Animal Health (Merck & Co.) is a major rival, offering vaccines, pharmaceuticals, and technology platforms while emphasizing One Health initiatives and expanding capabilities through strategic acquisitions such as recent aqua-health deals that bolster its vaccine and antiparasitic offerings for aquaculture. Boehringer Ingelheim maintains strength in vaccines and preventive care with a research-driven approach and extensive global reach, particularly in livestock and companion-animal vaccines where biotechnology and digital-health integration support disease prevention and productivity solutions. Elanco, despite strategic divestitures, remains significant through focused therapeutics and initiatives in companion-animal and food-animal health, addressing diseases such as parvovirus and investing in innovations across therapeutics and preventive measures.
IDEXX Laboratories is the diagnostics leader for veterinary practice, supplying rapid, proprietary diagnostic tests, laboratory services, and information-management systems that improve clinical workflows and support evidence-based care in small-animal clinics worldwide. Bayer (including its animal health assets historically and relevant product lines) and Boehringer’s positioned competitors contribute established pharmaceutical pipelines and vaccine portfolios that target major infectious and chronic conditions in animals, while companies like Ceva Santé Animale and Virbac focus on vaccines, parasiticides, and regionally tailored preventive and therapeutic products to serve both emerging and mature markets. Dechra concentrates on specialty veterinary pharmaceuticals for endocrinology, dermatology, and anti-infectives, complementing the market with branded and generic medicines aimed at practitioners seeking targeted treatment options. Patterson Veterinary Supply plays a critical distribution and services role by supplying equipment, diagnostics, and consumables to clinics, enabling product reach and practitioner access across North America and other markets.
Diagnostics and emerging biotech players round out the competitive landscape by advancing point-of-care testing, molecular diagnostics, and AI-driven tools that accelerate disease detection and treatment personalization. Thermo Fisher, Bio-Rad, Neogen, and BioMérieux are significant in laboratory and molecular diagnostics supporting veterinary infectious-disease testing, while agile companies and startups—ranging from Abaxis to specialized point-of-care and imaging innovators—are expanding rapid testing, digital diagnostics, and precision therapeutics that address unmet needs in both companion and production animals. Market reports project continued growth driven by rising pet ownership, livestock productivity demands, and technological adoption in diagnostics and therapeutics, positioning these ten major companies and allied diagnostic firms to shape clinical standards, surveillance capacity, and commercialization of next-generation animal health solutions.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for animal therapeutics and diagnostics by geography and historical trend. The scope of the report extends to sizing of the animal therapeutics and diagnostics market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Zoetis leads the animal therapeutics and diagnostics sector with a broad portfolio spanning vaccines, pharmaceuticals, diagnostics, and digital solutions for both companion animals and livestock, supported by sizable R&D investments and global manufacturing and distribution networks. Merck Animal Health (Merck & Co.) is a major rival, offering vaccines, pharmaceuticals, and technology platforms while emphasizing One Health initiatives and expanding capabilities through strategic acquisitions such as recent aqua-health deals that bolster its vaccine and antiparasitic offerings for aquaculture. Boehringer Ingelheim maintains strength in vaccines and preventive care with a research-driven approach and extensive global reach, particularly in livestock and companion-animal vaccines where biotechnology and digital-health integration support disease prevention and productivity solutions. Elanco, despite strategic divestitures, remains significant through focused therapeutics and initiatives in companion-animal and food-animal health, addressing diseases such as parvovirus and investing in innovations across therapeutics and preventive measures.
IDEXX Laboratories is the diagnostics leader for veterinary practice, supplying rapid, proprietary diagnostic tests, laboratory services, and information-management systems that improve clinical workflows and support evidence-based care in small-animal clinics worldwide. Bayer (including its animal health assets historically and relevant product lines) and Boehringer’s positioned competitors contribute established pharmaceutical pipelines and vaccine portfolios that target major infectious and chronic conditions in animals, while companies like Ceva Santé Animale and Virbac focus on vaccines, parasiticides, and regionally tailored preventive and therapeutic products to serve both emerging and mature markets. Dechra concentrates on specialty veterinary pharmaceuticals for endocrinology, dermatology, and anti-infectives, complementing the market with branded and generic medicines aimed at practitioners seeking targeted treatment options. Patterson Veterinary Supply plays a critical distribution and services role by supplying equipment, diagnostics, and consumables to clinics, enabling product reach and practitioner access across North America and other markets.
Diagnostics and emerging biotech players round out the competitive landscape by advancing point-of-care testing, molecular diagnostics, and AI-driven tools that accelerate disease detection and treatment personalization. Thermo Fisher, Bio-Rad, Neogen, and BioMérieux are significant in laboratory and molecular diagnostics supporting veterinary infectious-disease testing, while agile companies and startups—ranging from Abaxis to specialized point-of-care and imaging innovators—are expanding rapid testing, digital diagnostics, and precision therapeutics that address unmet needs in both companion and production animals. Market reports project continued growth driven by rising pet ownership, livestock productivity demands, and technological adoption in diagnostics and therapeutics, positioning these ten major companies and allied diagnostic firms to shape clinical standards, surveillance capacity, and commercialization of next-generation animal health solutions.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.